# Nuclide record re-188-sct (drug). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/drugs/re-188-sct/>
  a schema:Drug ;
  nuclide:kind "drug" ;
  schema:identifier "re-188-sct" ;
  schema:name "Rhenium-188 skin cancer therapy"@en ;
  schema:alternateName "Rhenium-SCT"@en, "188Re epidermal radionuclide therapy"@en, "Rhenium-SCT" ;
  schema:description "A radioactive paste is spread over a thin film placed on top of a skin cancer. The radiation only travels a few millimetres, so it treats the visible tumour without surgery, cutting, or affecting deeper tissue."@en ;
  schema:url <https://nuclide.cc/drugs/re-188-sct/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://www.oncobeta.com/technology/>, <https://pmc.ncbi.nlm.nih.gov/articles/PMC12197855/>, <https://www.healthcert.com/hubfs/EJNMMI%20Castellucci%20-%20Savoia%20et%20al.%202020.pdf>, <https://www.msac.gov.au/sites/default/files/2025-07/1657.1_final_psd_-_april_2025_-_redacted.pdf> ;
  nuclide:status "approved" ;
  nuclide:tag "brachytherapy", "skin cancer", "beta emitter", "non-invasive" ;
  nuclide:modality "brachytherapy source" ;
  nuclide:approval "EU/UK/AU/NZ/ZA 2015: Shallow (≤3 mm deep) basal cell carcinoma and squamous cell carcinoma without perineural invasion or high-risk pathology" ;
  nuclide:related <https://nuclide.cc/isotopes/re-188/> ;
  nuclide:technologies <https://nuclide.cc/technologies/ldr-seed-brachytherapy/> .